# Ultrafast Truxima Infusion in Non-Hodgkin's Lymphoma: Txagorapid Study

> **NCT05191225** · PHASE4 · UNKNOWN · sponsor: **Laida Cuevas Palomares** · enrollment: 48 (estimated)

## Conditions studied

- Non-Hodgkin's Lymphoma

## Interventions

- **DRUG:** RiTUXimab Injection [Truxima]
- **DRUG:** RiTUXimab Injection [Truxima]

## Key facts

- **NCT ID:** NCT05191225
- **Lead sponsor:** Laida Cuevas Palomares
- **Sponsor class:** NETWORK
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-09-28
- **Primary completion:** 2022-03
- **Final completion:** 2022-12
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2022-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05191225

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05191225, "Ultrafast Truxima Infusion in Non-Hodgkin's Lymphoma: Txagorapid Study". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05191225. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*